Sickle Cell Anaemia Test

In September 2024, the new test, developed by CSIR-Centre for Cellular & Molecular Biology (CSIR-CCMB), can identify sickle cell anaemia (SCA) status using just a drop of blood for under ₹100.

Key Highlights

PCR-Based Accuracy: The polymerase chain reaction (PCR) test, validated by ICMR, boasts 100% sensitivity and specificity, outperforming traditional methods.
Wide-Reaching Impact: Designed for tribal and non-tribal populations, the test has been implemented in Chhattisgarh, Maharashtra, and Rajasthan, with plans for expansion.
Immediate Diagnosis and Counseling: This test allows prenatal diagnostics, helping in early detection and genetic counseling, improving patient outcomes.
Collaboration for Better Treatment: CSIR is working with AIIMS and other institutions to expand the testing infrastructure, aiming to screen millions across affected states.
Hydroxyurea Treatment: The team is making the drug Hydroxyurea more accessible in child-friendly forms, addressing treatment gaps for young patients.